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AngioJet Ineffective for STEMI
Distal embolization of thrombus is thought to be a significant cause of “no reflow”after angioplasty for acute infarctions, and many strategies to reduce thrombus
burdenhave beenproposed.TheAngioJet device uses saline flow tobreak apart the clot
and then a suction catheter to remove the pieces. Ali and colleagues report the results of
the AiMI study, which randomized almost 500 patients with acute ST-segment
elevationmyocardial infarction to either standard percutaneous coronary intervention
(PCI) or rheolytic thrombectomyprior to balloon inflation.All of themajor endpoints
favored standard PCI, which had smaller infarct size, higher rates of post-procedural
Thrombolysis In Myocardial Infarction flow grade 3, and reduced 30-day mortality.
The group randomized toPCI did have anunexpectedly low (1%)30-daymortality,
which may explain some of the worse outcomes in the thrombectomy group, but this
trial provides no evidence that thrombectomy should be routinely performed. Rather,
this study suggests that routine thrombectomy is harmful. See page 244.
Page 260
Interventional Cardiology
Cost Comparisons of Drug-Eluting Stents
Two articles and an editorial in this issue compare the costs and benefits ofdrug-eluting stents. Bakhai and colleagues used data from the TAXUS-IV trial
along with supplemental assumptions about costs to determine if paclitaxel-eluting
stents (PES) are cost effective.Choosing aPES adds approximately $2,000 to the initial
procedure, but because of fewer costly target vessel revascularizations (TVRs) over the
subsequent year, the net cost is only $572 per PES. For patients without mandatory
angiographic follow-up, the extra cost was only $97 per patient. Elezi and colleagues
used data from the 450 patients enrolled in the ISAR trials, which randomized patients
to either sirolimus- or paclitaxel-eluting stents. In these two trials, sirolimus stents were
only half as likely to require TVR, resulting in total costs that were approximately
$2,000 less per patient.An editorial byVaitkus addresses the difficulties and limitations
inperforming these types of analyses andoffers suggestions tomake these analysesmore
relevant for decision-makers. See pages 253, 262, and 268. See figure.
Diabetes and
Cardiovascular Risk
Prediabetes and Cardiovascular Risk
Diabetes is a known cardiovascular risk factor and impaired fasting glucose (IFG)is thought to represent “prediabetes.” In 2003, the American Diabetes Associa-
tion lowered the threshold for diagnosing IFG from110mg/dl to 100mg/dl. Kim and
colleagues preformed a retrospective chart review to study the consequences of the new
definition and its relationship with cardiac risk. The prevalence of IFG in this group of
patients ages 30 to 69 years was found to increase from 8% to 35% with the new
definition. Compared to those with fasting glucose100 mg/dl, the odds ratio for a
previous cardiac event was not significantly different for those with a glucose level of
100 to 110 mg/dl, but was for those with a glucose level 110 mg/dl. This study
suggests that labeling one-third of patients with IFGmay dilute the significance of this
diagnosis in identifying those most in need of primary prevention. See page 293.
(continued) A-42Cardiac Imaging
Prevalence of Atherosclerosis by MSCT in Intermediate-Risk Patients
Hausleiter and colleagues used 64-slice coronary computed tomography to pro-spectively evaluate 160 patients with intermediate risk for occlusive coronary
artery disease; for example, those with chest pain on exertion but negative stress test or
positive stress test but no chest pain. Quantification of coronary calcium and identifi-
cation of atherosclerotic plaque were the primary measures. Approximately one-third
of patients had no calcium and no atherosclerotic plaque, one-third had only calcified
plaques, and the final one-third had both kinds of plaque. Only 6% had noncal-
cified plaques without additional areas of coronary calcium. Patients with noncal-
cifed plaques had higher low-density lipoprotein and C-reactive protein levels than
those with only calcified plaques. Computed tomographic angiography may be
useful in further risk-stratifying intermediate-risk individuals and in identifying
vulnerable plaques. See page 312.
Page 347
Heart Rhythm Disorders
Spectral Analysis of AF Ablation
Spectral analysis of electrocardiograms can be used to identify high-frequencysources that may perpetuate atrial fibrillation (AF). This technique uses either
standard or intracardiac electrocardiograms filtered for signals between 0 to 80 MHz;
the QRS complex is then mathematically subtracted and the frequency characteristics
of the remaining signal are transformed to identify adominant frequency (DF).Lemola
and colleagues report that the DF is higher during persistent than paroxysmal AF and
that both pulmonary vein isolation and electrogram-guided ablation reduce the DF,
although therewere differences in predicting long-term success based on these changes.
This technique may prove useful in understanding the pathophysiology of AF. See
page 340. See figure.
